Painful bladder syndrome: Is consensus possible? Melissa R. KaufmanHarriette M. ScarperoRoger R. Dmochowski OriginalPaper 24 November 2009 Pages: 177 - 181
Comparison of TURP, TUVRP, and HoLEP Narmada P. GuptaAjay Anand OriginalPaper 24 November 2009 Pages: 166 - 168
Diabetes and benign prostatic hyperplasia: Emerging clinical connections Aruna V. SarmaJ. Kellogg Parsons OriginalPaper 24 November 2009 Pages: 157 - 165
The role and structure of a postradical prostatectomy penile rehabilitation program John P. Mulhall OriginalPaper 24 November 2009 Pages: 148 - 154
What is the pathologist saying? Interpretation of the prostate pathology report Omar Hameed OriginalPaper 24 November 2009 Pages: 141 - 147
Phenotypic approach to the management of chronic prostatitis/chronic pelvic pain syndrome J. Curtis NickelDaniel Shoskes OriginalPaper 26 August 2009 Pages: 132 - 137
Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis Jaspreet S. Sandhu OriginalPaper 26 August 2009 Pages: 127 - 131
Dietary patterns, supplement use, and the risk of benign prostatic hyperplasia Kenneth S. PoonKevin T. McVary OriginalPaper 26 August 2009 Pages: 117 - 124
Self-management for men with lower urinary tract symptoms Christian T. BrownMark Emberton OriginalPaper 26 August 2009 Pages: 111 - 116
Salvage therapy for prostate cancer recurrence after radiation therapy Jared M. CoxJ. Erik Busby OriginalPaper 26 August 2009 Pages: 102 - 108
Radiation therapy approaches to the treatment of high-risk prostate cancer Soroush Rais-BahramiManish A. ViraLouis Potters OriginalPaper 26 August 2009 Pages: 95 - 101
Evaluation of chronic pelvic pain syndrome in men: Is it chronic prostatitis? Raymond M. BernalMichel A. Pontari OriginalPaper 21 July 2009 Pages: 85 - 91
Nonpharmacological approaches for the treatment of urological chronic pelvic pain syndromes in men Jeannette M. Potts OriginalPaper 21 July 2009 Pages: 79 - 84
Primary care physician versus urologist: How does their medical management of LUTS associated with BPH differ? Martin M. Miner OriginalPaper 21 July 2009 Pages: 70 - 76
Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity Anne K. MongiuKevin T. McVary OriginalPaper 21 July 2009 Pages: 63 - 69
Chemoprevention of prostate cancer: What can be recommended to patients? Janet L. ColliChristopher L. Amling OriginalPaper 21 July 2009 Pages: 47 - 53
Phytotherapy in chronic prostatitis Maximilien C. GorisThierry RoumeguereBob Djavan OriginalPaper 10 February 2009 Pages: 39 - 43
Ejaculatory duct dysfunction and chronic pelvic pain syndrome in men Harry Fisch OriginalPaper 10 February 2009 Pages: 35 - 38
Benign prostatic hyperplasia evaluation, association with sexual dysfunction, treatment, and practice patterns according to physician specialty Boback M. BerookhimMatthew L. SteinwayAllen D. Seftel OriginalPaper 10 February 2009 Pages: 25 - 31
Contemporary surgical management of benign prostatic hyperplasia: What do recent trends imply for urology training? Sean P. ElliottRobert M. Sweet OriginalPaper 10 February 2009 Pages: 19 - 24
The use of prostate-specific antigen kinetics to stratify risk in prostate cancer Joseph Presti Jr OriginalPaper 10 February 2009 Pages: 11 - 15
Watchful waiting versus active surveillance: Appropriate patient selection Marc A. Dall’EraChristopher J. Kane OriginalPaper 10 February 2009 Pages: 5 - 10
Phosphodiesterase type 5 inhibitors for the treatment of female sexual function Kevin T. McVary Clinical Trials Report 10 February 2009 Pages: 1 - 2
Ultrasound findings in patients with chronic prostatitis/chronic pelvic pain syndrome Alvin WeeDaniel A. Shoskes OriginalPaper 25 November 2008 Pages: 182 - 184
Urodynamic findings in chronic prostatitis and chronic pelvic floor pain Rajiv SainiJohn P. FitzgeraldFrederick A. Gulmi OriginalPaper 25 November 2008 Pages: 177 - 181
The impact of phosphodiesterase inhibitors on lower urinary tract symptoms Tobias S. KöhlerKevin T. McVary OriginalPaper 25 November 2008 Pages: 167 - 174
Dietary interventions in prostate cancer Wendy Demark-Wahnefried OriginalPaper 25 November 2008 Pages: 155 - 163
Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors Matthew R. Smith OriginalPaper 25 November 2008 Pages: 149 - 154
The role of pelvic floor therapies in chronic pelvic pain syndromes Rodney U. Anderson OriginalPaper 16 October 2008 Pages: 139 - 144
Evaluation and treatment of male pelvic pain syndromes and sexual dysfunction Darius A. Paduch OriginalPaper 16 October 2008 Pages: 131 - 138
Reduced intraoperative bleeding during transurethral resection of the prostate: Evaluation of finasteride, vascular endothelial growth factor, and CD34 Ettore De BerardinisGabriele AntoniniAntonella Rossi OriginalPaper 16 October 2008 Pages: 123 - 127
The role of botulinum toxin a in the management of lower urinary tract symptoms Al B. BarqawiE. David Crawford OriginalPaper 16 October 2008 Pages: 117 - 122
Role of radical prostatectomy in the treatment of high-risk prostate cancer Ofer YossepowitchJames A. Eastham OriginalPaper 16 October 2008 Pages: 107 - 114
Rationale for statins in the chemoprevention of prostate cancer Robert J. HamiltonStephen J. Freedland OriginalPaper 16 October 2008 Pages: 99 - 106
Atypical infections of the prostate Gilbert J. WiseAlex Shteynshlyuger OriginalPaper 31 May 2008 Pages: 86 - 93
Male chronic pelvic pain syndrome: Prevalence, risk factors, treatment patterns, and socioeconomic impact J. Quentin Clemens OriginalPaper 31 May 2008 Pages: 81 - 85
5-α-reductase inhibitor monotherapy for lower urinary tract symptoms following combination therapy with α-blockers: When is one medication enough? Ehab A. ElzayatMostafa M. Elhilali OriginalPaper 31 May 2008 Pages: 74 - 78
Inflammatory mechanisms associated with prostatic inflammation and lower urinary tract symptoms Jennifer L. St. SauverSteven J. Jacobsen OriginalPaper 31 May 2008 Pages: 67 - 73
The spectrum of prostate cancer care: From curative intent to palliation Ased S. M. AliFreddie C. Hamdy OriginalPaper 31 May 2008 Pages: 56 - 63
The basic biochemistry and molecular events of hormone therapy Elahe A. MostaghelRobert B. MontgomeryDaniel W. Lin OriginalPaper 31 May 2008 Pages: 47 - 55
Update on minimally invasive therapy for chronic prostatitis/chronic pelvic pain syndrome Christof Kastner OriginalPaper 30 March 2008 Pages: 33 - 38
Vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia Hartmut PorstPeter SandnerErnst Ulbrich OriginalPaper 30 March 2008 Pages: 24 - 30
JM-27: A biomarker for symptomatic benign prostatic hyperplasia and lower urinary tract symptoms Grant W. CannonRobert H. Getzenberg OriginalPaper 30 March 2008 Pages: 19 - 23
Testosterone replacement therapy and prostate cancer: A Word of Caution Timothy C. BrandEdith Canby-HaginoIan M. Thompson OriginalPaper 30 March 2008 Pages: 11 - 15
